Edition:
United Kingdom

Kura Oncology Inc (KURA.OQ)

KURA.OQ on NASDAQ Stock Exchange Global Select Market

22.75USD
23 Feb 2018
Change (% chg)

$0.60 (+2.71%)
Prev Close
$22.15
Open
$22.35
Day's High
$23.05
Day's Low
$22.00
Volume
63,902
Avg. Vol
79,848
52-wk High
$24.00
52-wk Low
$5.90

Select another date:

Thu, Nov 9 2017

BRIEF-Kura Oncology files for mixed shelf offering of up to $200 mln - SEC filing‍​

* Kura Oncology Inc - files for mixed shelf offering of up to $200 million - SEC filing‍​ Source text:(http://bit.ly/2yNnKBA) Further company coverage:

BRIEF-Kura Oncology Inc entered into amendment to its sales agreement with Cowen and Co

* Kura Oncology Inc - on Nov 9, 2017, co entered into amendment to its sales agreement, dated January 27, 2017 with Cowen and Company LLC ‍​-SEC filing

BRIEF-Kura Oncology reports third quarter 2017 financial results

* Kura Oncology reports third quarter 2017 financial results and provides corporate update

BRIEF-KURA ONCOLOGY ‍CONFIRMS PARTIAL RESPONSES OBSERVED IN PATIENTS WITH HRAS MUTANT HNSCC IN TRIAL

* KURA ONCOLOGY LEAD CANDIDATE TIPIFARNIB SHOWS DURABLE ANTI-TUMOR ACTIVITY IN HRAS MUTANT HEAD AND NECK CANCER IN AACR-NCI-EORTC UPDATE

BRIEF-Kura Oncology announces positive phase 2 study for Tipifarnib in HRAS mutant head and neck cancer

* Kura Oncology announces positive phase 2 study for Tipifarnib in HRAS mutant head and neck cancer

Select another date: